Total Payments
$49,506
2024 Payments
$4,571
Companies
16
Transactions
146
Medicare Patients
2,529
Medicare Billing
$436,339
Payment Breakdown by Category
Consulting$26,344 (53.2%)
Other$20,169 (40.7%)
Food & Beverage$2,916 (5.9%)
Travel$69.32 (0.1%)
Education$7.90 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $26,344 | 50 | 53.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,625 | 7 | 37.6% |
| Food and Beverage | $2,916 | 84 | 5.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,544 | 2 | 3.1% |
| Travel and Lodging | $69.32 | 2 | 0.1% |
| Education | $7.90 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $30,131 | 101 | $0 (2024) |
| PFIZER INC. | $19,003 | 26 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $87.96 | 5 | $0 (2024) |
| Akcea Therapeutics, Inc. | $41.97 | 1 | $0 (2019) |
| Kestra Medical Technology Services, Inc. | $35.07 | 1 | $0 (2024) |
| Relypsa, Inc. | $31.80 | 2 | $0 (2017) |
| Edwards Lifesciences Corporation | $22.39 | 1 | $0 (2023) |
| Prytime Medical Devices, Inc. | $21.06 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $19.62 | 1 | $0 (2024) |
| ATRICURE, INC. | $18.61 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,571 | 13 | Abbott Laboratories ($4,495) |
| 2023 | $8,554 | 30 | Abbott Laboratories ($5,065) |
| 2022 | $5,367 | 16 | Abbott Laboratories ($2,730) |
| 2021 | $12,291 | 15 | PFIZER INC. ($7,575) |
| 2020 | $4,495 | 9 | PFIZER INC. ($2,744) |
| 2019 | $3,049 | 9 | PFIZER INC. ($2,645) |
| 2018 | $1,834 | 9 | Abbott Laboratories ($1,834) |
| 2017 | $9,345 | 45 | Abbott Laboratories ($9,195) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.62 | General |
| Category: Cardiovascular | ||||||
| 08/30/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $127.17 | General |
| Category: Heart Failure | ||||||
| 07/19/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $35.07 | General |
| Category: Cardiology | ||||||
| 07/18/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $712.50 | General |
| Category: Heart Failure | ||||||
| 07/18/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $475.00 | General |
| Category: Heart Failure | ||||||
| 07/18/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $475.00 | General |
| Category: Heart Failure | ||||||
| 07/04/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Consulting Fee | Cash or cash equivalent | $1,306.25 | General |
| Category: Heart Failure | ||||||
| 07/04/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Consulting Fee | Cash or cash equivalent | $712.50 | General |
| Category: Heart Failure | ||||||
| 07/04/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Consulting Fee | Cash or cash equivalent | $593.75 | General |
| Category: Heart Failure | ||||||
| 07/04/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Travel and Lodging | In-kind items and services | $60.30 | General |
| Category: Heart Failure | ||||||
| 07/04/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Heart Failure | ||||||
| 05/30/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Heart Failure | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/20/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Consulting Fee | Cash or cash equivalent | $878.75 | General |
| Category: Heart Failure | ||||||
| 12/20/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Consulting Fee | Cash or cash equivalent | $118.75 | General |
| Category: Heart Failure | ||||||
| 12/18/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/17/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $22.39 | General |
| 11/09/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $147.48 | General |
| Category: Heart Failure | ||||||
| 10/24/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $90.37 | General |
| Category: Heart Failure | ||||||
| 10/24/2023 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Genetic Disease | ||||||
| 10/12/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Consulting Fee | Cash or cash equivalent | $665.00 | General |
| Category: Heart Failure | ||||||
| 10/12/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Consulting Fee | Cash or cash equivalent | $475.00 | General |
| Category: Heart Failure | ||||||
| 10/12/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Consulting Fee | Cash or cash equivalent | $475.00 | General |
| Category: Heart Failure | ||||||
| 10/06/2023 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/30/2023 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 667 | 1,267 | $267,175 | $103,736 |
| 2022 | 13 | 611 | 1,282 | $255,156 | $107,012 |
| 2021 | 15 | 711 | 1,380 | $262,479 | $117,409 |
| 2020 | 13 | 540 | 1,295 | $277,573 | $108,182 |
Total Patients
2,529
Total Services
5,224
Medicare Billing
$436,339
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 167 | $45,925 | $16,129 | 35.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 57 | 91 | $31,850 | $12,849 | 40.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 45 | 127 | $24,130 | $12,339 | 51.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 24 | 67 | $31,825 | $11,588 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 168 | $31,920 | $11,417 | 35.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 175 | $22,750 | $11,244 | 49.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 51 | 51 | $21,675 | $8,917 | 41.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 33 | 39 | $14,040 | $5,316 | 37.9% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 22 | 129 | $15,480 | $4,253 | 27.5% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2023 | 17 | 61 | $8,540 | $2,558 | 30.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 20 | $4,900 | $2,137 | 43.6% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2023 | 24 | 34 | $5,950 | $1,908 | 32.1% |
| 93750 | Evaluation of lower heart chamber assist device | Office | 2023 | 11 | 29 | $3,480 | $1,171 | 33.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 20 | $1,500 | $816.60 | 54.4% |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 2023 | 11 | 22 | $1,870 | $548.46 | 29.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 48 | 67 | $1,340 | $546.00 | 40.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 71 | 319 | $41,470 | $18,780 | 45.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 164 | $38,485 | $16,818 | 43.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 59 | 185 | $35,695 | $15,484 | 43.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 77 | $22,800 | $11,075 | 48.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 61 | $29,404 | $11,007 | 37.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 42 | 46 | $15,940 | $7,570 | 47.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 38 | 38 | $14,800 | $6,719 | 45.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 100 | $16,220 | $6,715 | 41.4% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2022 | 15 | 146 | $19,495 | $4,929 | 25.3% |
About Dr. Donald Haas, MD
Dr. Donald Haas, MD is a Cardiovascular Disease healthcare provider based in Abington, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205876406.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donald Haas, MD has received a total of $49,506 in payments from pharmaceutical and medical device companies, with $4,571 received in 2024. These payments were reported across 146 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($26,344).
As a Medicare-enrolled provider, Haas has provided services to 2,529 Medicare beneficiaries, totaling 5,224 services with total Medicare billing of $436,339. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Advanced Heart Failure and Transplant Cardiology
- Location Abington, PA
- Active Since 06/07/2006
- Last Updated 09/05/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1205876406
Products in Payments
- VYNDAQEL (Drug) $18,967
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $8,902
- Circulatory Support (Device) $6,164
- CardioMEMS HF System (Device) $4,764
- HeartMate 3 Left Ventricular Assist Device (Device) $4,716
- CARDIOMEMS (Device) $3,206
- HeartMate II LVAS (Device) $1,625
- HeartMate 3 Left Ventricular Dev (Device) $355.09
- HeartMate (Device) $215.92
- ENTRESTO (Drug) $66.38
- MITRACLIP (Device) $64.21
- XIENCE V (Device) $48.19
- TEGSEDI (Drug) $41.97
- VYNDAMAX (Drug) $36.03
- Assure WCD (Device) $35.07
- Veltassa (Drug) $31.80
- XIENCE SIERRA (Device) $24.25
- NC TREK NEO (Device) $23.57
- XIENCE SKYPOINT (Device) $22.54
- LEQVIO (Drug) $21.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Abington
Dr. Manoj Muttreja, M.d, M.D
Cardiovascular Disease — Payments: $86,154
Cardiovascular Disease $86,154
Dr. Charles Gottlieb, M.d, M.D
Cardiovascular Disease — Payments: $56,892
Cardiovascular Disease $56,892
Jennifer Mazzoni Clifford, D.o, D.O
Cardiovascular Disease — Payments: $15,390
Cardiovascular Disease $15,390
Dr. Stephen Teich, M.d, M.D
Cardiovascular Disease — Payments: $129.92
Cardiovascular Disease $129.92
Dr. David Eskin, Md, MD
Cardiovascular Disease — Payments: $24.56
Cardiovascular Disease $24.56
Dr. Linda Kollmar, M.d, M.D
Cardiovascular Disease
Cardiovascular Disease